← All organizations
Highest phase reached
Phase 3
First clinical trial
Jan 24, 2019Last known activity
Oct 31, 2024
Timeline
No events for the selected filters.
Drugs by trial phase (10 distinct, 4 trials)
Phase 3 (5 own, 0 via acquisition)
Phase 2 (5 own, 0 via acquisition)
Indications
Studied for
Recent trials (4)
- NCT06552234CollaboratorPhase 2Oct 31, 2024
- NCT06393816CollaboratorPhase 2Jun 13, 2024
- NCT04547504CollaboratorPhase 3Dec 22, 2020
- NCT03801304CollaboratorPhase 2Jan 24, 2019
Details
- Last known activity
- Oct 31, 2024